Gyre Therapeutics
GYRE
GYRE
65 hedge funds and large institutions have $75.5M invested in Gyre Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
14% less capital invested
Capital invested by funds: $87.7M → $75.5M (-$12.2M)
71% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 31
Holders
65
Holding in Top 10
2
Calls
$5.11M
Puts
$84K
Top Buyers
| 1 | +$2.44M | |
| 2 | +$1.53M | |
| 3 | +$435K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$268K |
| 5 |
JGC
J. Goldman & Co
New York
|
+$250K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$1.68M | |
| 3 | -$1.68M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.32M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.07M |